Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover comparison of immediate-release oral levodopa and levodopa/carbidopa intestinal gel on cognition and mood in advanced Parkinson's disease
2015-002631-17Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa and carbidopa + levodopa in Parkinson's disease (PD) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Cognitive task performance over time. Started Nov 2015; status: completed.
02
Drugs
levodopacarbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-002631-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002631-17.